$1.68
4.00% yesterday
Nasdaq, Sep 27, 10:00 pm CET
ISIN
US68236V1044
Symbol
ATNF
Sector
Industry

180 Life Sciences Corp Stock price

$1.68
-0.23 12.04% 1M
-0.33 16.42% 6M
-2.38 58.59% YTD
-9.53 85.01% 1Y
-2,190.92 99.92% 3Y
-3,988.32 99.96% 5Y
-3,684.32 99.95% 10Y
Nasdaq, Closing price Fri, Sep 27 2024
-0.07 4.00%
ISIN
US68236V1044
Symbol
ATNF
Sector
Industry

Key metrics

Market capitalization $900.00k
Enterprise Value $190.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio negative
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-8.93m
Free Cash Flow (TTM) Free Cash Flow $-4.24m
Cash position $1.15m
EPS (TTM) EPS $-28.49
Short interest 5.95%
Show more

Is 180 Life Sciences Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

180 Life Sciences Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast 180 Life Sciences Corp:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast 180 Life Sciences Corp:

Buy
100%

Financial data from 180 Life Sciences Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
- -
-
100%
- Direct Costs 0.10 0.10
0% 0%
-
-0.10 -0.10
0% 0%
-
- Selling and Administrative Expenses 6.50 6.50
57% 57%
-
- Research and Development Expense 2.23 2.23
24% 24%
-
-8.83 -8.83
51% 51%
-
- Depreciation and Amortization 0.10 0.10
0% 0%
-
EBIT (Operating Income) EBIT -8.93 -8.93
51% 51%
-
Net Profit -13 -13
76% 76%
-

In millions USD.

Don't miss a Thing! We will send you all news about 180 Life Sciences Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

180 Life Sciences Corp Stock News

Neutral
GlobeNewsWire
16 days ago
PALO ALTO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (“180” or the “Company”) is pleased to announce the appointment of Omar Jimenez as its new Chief Financial Officer, effective September 30, 2024. Mr. Jimenez, already a director of the Company, will play a key role in driving the financial strategy of the Company as it continues to grow and innovate in the pharma and ...
Neutral
GlobeNewsWire
2 months ago
PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- PALO ALTO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced topline results from a clinical pharmacology study (the “Study”), that evaluated the uptake of cannabidiol (CBD) in a solid formulation which can be delivered as a pill orally. The clinical trial ...
Neutral
GlobeNewsWire
3 months ago
PALO ALTO, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Hearings Panel has determined to grant the Company's request to continue its listing on The Nasdaq Stock M...
More 180 Life Sciences Corp News

Company Profile

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded in 2016 and is headquartered in Menlo Park, CA.

Head office United States
CEO Blair Jordan
Employees 4
Founded 2016
Website www.180lifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today